Condition
Vasoplegic Shock
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Unknown1
Not Yet Recruiting1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07671365Phase 4Not Yet RecruitingPrimary
Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)
NCT05833828Recruiting
Differential Regulation of RAAS-axis in Patients Undergoing Cardiac Surgery
NCT05925348Unknown
Endotoxinemia and Vasoplegia Following Cardiothoracic Surgery With Cardiopulmonary Bypass (CPB)
Showing all 3 trials